...as Medtronic’s pump currently does. No Medicare code for sensor-augmented insulin pumps would deal a serious blow to efforts to produce a closed-loop “artificial pancreas,” since without a code, there’s no way a company could actually bill for such a product. (Oh, and side note: Medicare doesn’t have a coverage...
Search Results for: catherine price medtronic
...eyes. Thank you to Medtronic, the FDA, and everyone else working to make the dream of a closed loop system one step closer to reality. Here’s a link to the Medtronic press release. (They’re taking orders for the new system now, though it won’t ship for a while, until Medtronic...
...President of Marketing and Commercial Development, who explained to me how it works. Basically, unlike the current CGMs on the market (Dexcom’s Platinum G4 and Medtronic’s Guardian), the Symphony does not actually puncture the skin. Instead it’s trans-dermal, meaning it reads glucose levels through the skin’s top layer. If I...
...the exhibit hall: 1. Medtronic, maker of the Minimed insulin pump, has just launched a pretty amazing-sounding educational program geared toward guiding new pump and CGM (continuous glucose monitor) users through their first six months on insulin pump/CGM therapy. Called Start Right, the goal is to help new pumpers transition...
This summer I met Catherine Price for the first time. I had been looking forward to this meeting for a long time and when we met and hung out I felt as if I have known her for ages. Catherine, Jess, and I met at a café’ in Philly. Catherine...
When I was at the ADA Scientific Sessions in June, I had the chance to sit down with John Mastrototaro, Vice President of Research and Development for the diabetes business unit at Medtronic, and talk with him about some of Medtronic’s upcoming products and projects for people with diabetes. I...
...enthusiastic people from companies like Medtronic, J&J, Dexcom, Novo Nordisk, Sanofi-Aventis, Abbott, and Tandem Diabetes Care, to name a few. (If you ever find yourself getting cynical about pharma, I suggest you try to meet some of the people at these companies in person. I was truly impressed by their...
...VP of research and development in its diabetes unit, and the importance of exercise and diabetes management. It’s been a whirlwind! I’m also tweeting from catherine_price . Send questions and comments my way. 12:24 Conversation with Mads Krogsgaard Thomsen, Executive VP and Chief Science Officer at Novo Nordisk About Oral...
I’m at the 2012 ADA Scientific Sessions and am keeping a live blog about my experiences (here’s a link to my day 1 coverage of the ADA scientific sessions). I’m also tweeting about from at catherine_price, at hashtag #ADA2012. Included in this round: an interview with John Mastrototaro, Vice President...
Today marks the start of the 2012 American Diabetes Association (ADA) Scientific Sessions, being held this year in Philadelphia. I’ll be heading over there later today to check out what’s going on and live-blogging my experience (and sending Twitter updates via catherine_price, hashtag #ADA2012). 5:32 p.m. Checking out of CGM...